Mohamed TMA, Ang Y-S, Radzinsky E, Zhou P, Huang Y, Elfenbein A, Foley A, Magnitsky S, Srivastava D.  2018.  Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration.. Cell. 173(1):104-116.e12.
Manheimer KB, Patel N, Richter F, Gorham J, Tai AC, Homsy J, Boskovski MT, Parfenov M, Goldmuntz E, Chung WK et al..  2018.  Robust identification of deletions in exome and genome sequence data based on clustering of Mendelian errors.. Hum Mutat.
Jin SChih, Homsy J, Zaidi S, Lu Q, Morton S, DePalma SR, Zeng X, Qi H, Chang W, Sierant MC et al..  2017.  Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands.. Nat Genet. 49(11):1593-1601.
Ribeiro AJS, Schwab O, Mandegar MA, Ang Y-S, Conklin BR, Srivastava D, Pruitt BL.  2017.  Multi-Imaging Method to Assay the Contractile Mechanical Output of Micropatterned Human iPSC-Derived Cardiac Myocytes.. Circ Res. 120(10):1572-1583.
Theodoris CV, Mourkioti F, Huang Y, Ranade SS, Liu L, Blau HM, Srivastava D.  2017.  Long telomeres protect against age-dependent cardiac disease caused by NOTCH1 haploinsufficiency.. J Clin Invest. 127(5):1683-1688.
Mohamed TMA, Stone NR, Berry EC, Radzinsky E, Huang Y, Pratt K, Ang Y-S, Yu P, Wang H, Tang S et al..  2017.  Chemical Enhancement of In Vitro and In Vivo Direct Cardiac Reprogramming.. Circulation. 135(10):978-995.
Judge LM, Perez-Bermejo JA, Truong A, Ribeiro AJs, Yoo JC, Jensen CL, Mandegar MA, Huebsch N, Kaake RM, So P-L et al..  2017.  A BAG3 chaperone complex maintains cardiomyocyte function during proteotoxic stress.. JCI Insight. 2(14)
Duan Q, McMahon S, Anand P, Shah H, Thomas S, Salunga HT, Huang Y, Zhang R, Sahadevan A, Lemieux ME et al..  2017.  BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure.. Sci Transl Med. 9(390)
Zhu J-Y, Heidersbach A, Kathiriya IS, Garay BI, Ivey KN, Srivastava D, Han Z, King IN.  2017.  The E3 ubiquitin ligase Nedd4/Nedd4L is directly regulated by microRNA 1.. Development. 144(5):866-875.
Srivastava D, DeWitt N.  2016.  In Vivo Cellular Reprogramming: The Next Generation.. Cell. 166(6):1386-1396.
Zhang Y, Cao N, Huang Y, C Spencer I, Fu J-D, Yu C, Liu K, Nie B, Xu T, Li K et al..  2016.  Expandable Cardiovascular Progenitor Cells Reprogrammed from Fibroblasts.. Cell Stem Cell. 18(3):368-81.
Cao N, Huang Y, Zheng J, C Spencer I, Zhang Y, Fu J-D, Nie B, Xie M, Zhang M, Wang H et al..  2016.  Conversion of human fibroblasts into functional cardiomyocytes by small molecules.. Science. 352(6290):1216-20.
Kime C, Mandegar MA, Srivastava D, Yamanaka S, Conklin BR, Rand TA.  2016.  Efficient CRISPR/Cas9-Based Genome Engineering in Human Pluripotent Stem Cells.. Curr Protoc Hum Genet. 88:Unit21.4.
Gifford CA, Srivastava D.  2016.  Heart disease modelling adds a Notch to its belt.. Nat Cell Biol. 18(1):3-5.
Ang Y-S, Rivas RN, Ribeiro AJS, Srivas R, Rivera J, Stone NR, Pratt K, Mohamed TMA, Fu J-D, C Spencer I et al..  2016.  Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis.. Cell. 167(7):1734-1749.e22.
Huebsch N, Loskill P, Deveshwar N, C Spencer I, Judge LM, Mandegar MA, Fox CB, Mohamed TMA, Ma Z, Mathur A et al..  2016.  Miniaturized iPS-Cell-Derived Cardiac Muscles for Physiologically Relevant Drug Response Analyses.. Sci Rep. 6:24726.
Sia J, Yu P, Srivastava D, Li S.  2016.  Effect of biophysical cues on reprogramming to cardiomyocytes.. Biomaterials. 103:1-11.
Wang Z, Zhang X-J, Ji Y-X, Zhang P, Deng K-Q, Gong J, Ren S, Wang X, Chen I, Wang H et al..  2016.  The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy.. Nat Med. 22(10):1131-1139.
Barruet E, Morales BM, Lwin W, White MP, Theodoris CV, Kim H, Urrutia A, Wong SAnne, Srivastava D, Hsiao EC.  2016.  The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling.. Stem Cell Res Ther. 7(1):115.
Haldar SM, Srivastava D.  2016.  Sarcomeres and Cardiac Growth: Tension in the Relationship.. Trends Mol Med. 22(7):530-533.
Ribeiro AJS, Ang Y-S, Fu J-D, Rivas RN, Mohamed TMA, Higgs GC, Srivastava D, Pruitt BL.  2015.  Contractility of single cardiomyocytes differentiated from pluripotent stem cells depends on physiological shape and substrate stiffness.. Proc Natl Acad Sci U S A. 112(41):12705-10.
Kime C, Rand TA, Ivey KN, Srivastava D, Yamanaka S, Tomoda K.  2015.  Practical Integration-Free Episomal Methods for Generating Human Induced Pluripotent Stem Cells.. Curr Protoc Hum Genet. 87:21.2.1-21.
Srivastava D, Yu P.  2015.  Recent advances in direct cardiac reprogramming.. Curr Opin Genet Dev. 34:77-81.
Theodoris CV, Li M, White MP, Liu L, He D, Pollard KS, Bruneau BG, Srivastava D.  2015.  Human disease modeling reveals integrated transcriptional and epigenetic mechanisms of NOTCH1 haploinsufficiency.. Cell. 160(6):1072-86.
Ivey KN, Srivastava D.  2015.  microRNAs as Developmental Regulators.. Cold Spring Harb Perspect Biol. 7(7):a008144.
White MP, Theodoris CV, Liu L, Collins WJ, Blue KW, Lee JHo, Meng X, Robbins RC, Ivey KN, Srivastava D.  2015.  NOTCH1 regulates matrix gla protein and calcification gene networks in human valve endothelium.. J Mol Cell Cardiol. 84:13-23.
Funato N, Nakamura M, Richardson JA, Srivastava D, Yanagisawa H.  2015.  Loss of Tbx1 induces bone phenotypes similar to cleidocranial dysplasia.. Hum Mol Genet. 24(2):424-35.
Vedantham V, Galang G, Evangelista M, Deo RC, Srivastava D.  2015.  RNA sequencing of mouse sinoatrial node reveals an upstream regulatory role for Islet-1 in cardiac pacemaker cells.. Circ Res. 116(5):797-803.
King IN, Yartseva V, Salas D, Kumar A, Heidersbach A, D Ando M, Stallings NR, Elliott JL, Srivastava D, Ivey KN.  2014.  The RNA-binding protein TDP-43 selectively disrupts microRNA-1/206 incorporation into the RNA-induced silencing complex.. J Biol Chem. 289(20):14263-71.
Wang H, Cao N, C Spencer I, Nie B, Ma T, Xu T, Zhang Y, Wang X, Srivastava D, Ding S.  2014.  Small molecules enable cardiac reprogramming of mouse fibroblasts with a single factor, Oct4.. Cell Rep. 6(5):951-60.
Hu H, Roach JC, Coon H, Guthery SL, Voelkerding KV, Margraf RL, Durtschi JD, Tavtigian SV, Wu W, Scheet P et al..  2014.  A unified test of linkage analysis and rare-variant association for analysis of pedigree sequence data.. Nat Biotechnol. 32(7):663-9.
Worringer KA, Rand TA, Hayashi Y, Sami S, Takahashi K, Tanabe K, Narita M, Srivastava D, Yamanaka S.  2014.  The let-7/LIN-41 pathway regulates reprogramming to human induced pluripotent stem cells by controlling expression of prodifferentiation genes.. Cell Stem Cell. 14(1):40-52.
Qian L, Srivastava D.  2013.  Direct cardiac reprogramming: from developmental biology to cardiac regeneration.. Circ Res. 113(7):915-21.
Srivastava D, Berry EC.  2013.  Cardiac reprogramming: from mouse toward man.. Curr Opin Genet Dev. 23(5):574-8.
Heidersbach A, Saxby C, Carver-Moore K, Huang Y, Ang Y-S, de Jong PJ, Ivey KN, Srivastava D.  2013.  microRNA-1 regulates sarcomere formation and suppresses smooth muscle gene expression in the mammalian heart.. Elife. 2:e01323.
Srivastava D, Heidersbach AJ.  2013.  Small solutions to big problems: microRNAs for cardiac regeneration.. Circ Res. 112(11):1412-4.
Qian L, Berry EC, Fu J-D, Ieda M, Srivastava D.  2013.  Reprogramming of mouse fibroblasts into cardiomyocyte-like cells in vitro.. Nat Protoc. 8(6):1204-15.
Cheng P, Andersen P, Hassel D, Kaynak BL, Limphong P, Juergensen L, Kwon C, Srivastava D.  2013.  Fibronectin mediates mesendodermal cell fate decisions.. Development. 140(12):2587-96.
Vedantham V, Evangelista M, Huang Y, Srivastava D.  2013.  Spatiotemporal regulation of an Hcn4 enhancer defines a role for Mef2c and HDACs in cardiac electrical patterning.. Dev Biol. 373(1):149-62.
White MP, Rufaihah AJ, Liu L, Ghebremariam YT, Ivey KN, Cooke JP, Srivastava D.  2013.  Limited gene expression variation in human embryonic stem cell and induced pluripotent stem cell-derived endothelial cells.. Stem Cells. 31(1):92-103.
Wamstad JA, Alexander JM, Truty RM, Shrikumar A, Li F, Eilertson KE, Ding H, Wylie JN, Pico AR, Capra JA et al..  2012.  Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage.. Cell. 151(1):206-20.
Farina NH, Hausburg M, Betta NDalla, Pulliam C, Srivastava D, Cornelison D, Olwin BB.  2012.  A role for RNA post-transcriptional regulation in satellite cell activation.. Skelet Muscle. 2(1):21.
Hassel D, Cheng P, White MP, Ivey KN, Kroll J, Augustin HG, Katus HA, Stainier DYR, Srivastava D.  2012.  MicroRNA-10 regulates the angiogenic behavior of zebrafish and human endothelial cells by promoting vascular endothelial growth factor signaling.. Circ Res. 111(11):1421-33.
Plath K, Srivastava D, Alvarez-Buylla A, Tanaka EM, Kriegstein AR.  2012.  Stem cells in the land of the rising sun: ISSCR 2012.. Cell Stem Cell. 11(5):607-14.
Kathiresan S, Srivastava D.  2012.  Genetics of human cardiovascular disease.. Cell. 148(6):1242-57.
Srivastava D, Ieda M.  2012.  Critical factors for cardiac reprogramming.. Circ Res. 111(1):5-8.
Funato N, Nakamura M, Richardson JA, Srivastava D, Yanagisawa H.  2012.  Tbx1 regulates oral epithelial adhesion and palatal development.. Hum Mol Genet. 21(11):2524-37.
Tomoda K, Takahashi K, Leung K, Okada A, Narita M, N Yamada A, Eilertson KE, Tsang P, Baba S, White MP et al..  2012.  Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells.. Cell Stem Cell. 11(1):91-9.
Park CYon, Jeker LT, Carver-Moore K, Oh A, Liu HJiin, Cameron R, Richards H, Li Z, Adler D, Yoshinaga Y et al..  2012.  A resource for the conditional ablation of microRNAs in the mouse.. Cell Rep. 1(4):385-91.
Misra C, Sachan N, McNally CRothrock, Koenig SN, Nichols HA, Guggilam A, Lucchesi PA, Pu WT, Srivastava D, Garg V.  2012.  Congenital heart disease-causing Gata4 mutation displays functional deficits in vivo.. PLoS Genet. 8(5):e1002690.
Roach JC, Glusman G, Hubley R, Montsaroff SZ, Holloway AK, Mauldin DE, Srivastava D, Garg V, Pollard KS, Galas DJ et al..  2011.  Chromosomal haplotypes by genetic phasing of human families.. Am J Hum Genet. 89(3):382-97.
Shieh JTC, Huang Y, Gilmore J, Srivastava D.  2011.  Elevated miR-499 levels blunt the cardiac stress response.. PLoS One. 6(5):e19481.
Qian L, Van Laake LW, Huang Y, Liu S, Wendland MF, Srivastava D.  2011.  miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes.. J Exp Med. 208(3):549-60.
Tsuchihashi T, Maeda J, Shin CH, Ivey KN, Black BL, Olson EN, Yamagishi H, Srivastava D.  2011.  Hand2 function in second heart field progenitors is essential for cardiogenesis.. Dev Biol. 351(1):62-9.
Qian L, Wythe JD, Liu J, Cartry J, Vogler G, Mohapatra B, Otway RT, Huang Y, King IN, Maillet M et al..  2011.  Tinman/Nkx2-5 acts via miR-1 and upstream of Cdc42 to regulate heart function across species.. J Cell Biol. 193(7):1181-96.
Li Q, Kannan A, DeMayo FJ, Lydon JP, Cooke PS, Yamagishi H, Srivastava D, Bagchi MK, Bagchi IC.  2011.  The antiproliferative action of progesterone in uterine epithelium is mediated by Hand2.. Science. 331(6019):912-6.
Yu S, Crawford D, Tsuchihashi T, Behrens TW, Srivastava D.  2011.  The chemokine receptor CXCR7 functions to regulate cardiac valve remodeling.. Dev Dyn. 240(2):384-93.
Kwon C, Cheng P, King IN, Andersen P, Shenje L, Nigam V, Srivastava D.  2011.  Notch post-translationally regulates β-catenin protein in stem and progenitor cells.. Nat Cell Biol. 13(10):1244-51.
King IN, Qian L, Liang J, Huang Y, Shieh JTC, Kwon C, Srivastava D.  2011.  A genome-wide screen reveals a role for microRNA-1 in modulating cardiac cell polarity.. Dev Cell. 20(4):497-510.
Fish JE, Wythe JD, Xiao T, Bruneau BG, Stainier DYR, Srivastava D, Woo S.  2011.  A Slit/miR-218/Robo regulatory loop is required during heart tube formation in zebrafish.. Development. 138(7):1409-19.
Maitra M, Koenig SN, Srivastava D, Garg V.  2010.  Identification of GATA6 sequence variants in patients with congenital heart defects.. Pediatr Res. 68(4):281-5.
Park CYon, Pierce SA, von Drehle M, Ivey KN, Morgan JA, Blau HM, Srivastava D.  2010.  skNAC, a Smyd1-interacting transcription factor, is involved in cardiac development and skeletal muscle growth and regeneration.. Proc Natl Acad Sci U S A. 107(48):20750-5.
Ivey KN, Srivastava D.  2010.  MicroRNAs as regulators of differentiation and cell fate decisions.. Cell Stem Cell. 7(1):36-41.
Nigam V, Sievers HH, Jensen BC, Sier HA, Simpson PC, Srivastava D, Mohamed SA.  2010.  Altered microRNAs in bicuspid aortic valve: a comparison between stenotic and insufficient valves.. J Heart Valve Dis. 19(4):459-65.
Fish JE, Yan MS, Matouk CC, St Bernard R, Ho JJDavid, Ho JJDavid, Gavryushova A, Srivastava D, Marsden PA.  2010.  Hypoxic repression of endothelial nitric-oxide synthase transcription is coupled with eviction of promoter histones.. J Biol Chem. 285(2):810-26.
Sheehy NT, Cordes KR, White MP, Ivey KN, Srivastava D.  2010.  The neural crest-enriched microRNA miR-452 regulates epithelial-mesenchymal signaling in the first pharyngeal arch.. Development. 137(24):4307-16.
Van Laake LW, Qian L, Cheng P, Huang Y, Hsiao EC, Conklin BR, Srivastava D.  2010.  Reporter-based isolation of induced pluripotent stem cell- and embryonic stem cell-derived cardiac progenitors reveals limited gene expression variance.. Circ Res. 107(3):340-7.
Ieda M, Fu J-D, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG, Srivastava D.  2010.  Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors.. Cell. 142(3):375-86.
Cordes KR, Srivastava D, Ivey KN.  2010.  MicroRNAs in cardiac development.. Pediatr Cardiol. 31(3):349-56.
Qian L, Srivastava D.  2010.  Monkeying around with cardiac progenitors: hope for the future.. J Clin Invest. 120(4):1034-6.
Shrivastava S, Srivastava D, Olson EN, J DiMaio M, Bock-Marquette I.  2010.  Thymosin beta4 and cardiac repair.. Ann N Y Acad Sci. 1194:87-96.
Bock-Marquette I, Shrivastava S, Pipes GCTeg, Thatcher JE, Blystone A, Shelton JM, Galindo CL, Melegh B, Srivastava D, Olson EN et al..  2009.  Thymosin beta4 mediated PKC activation is essential to initiate the embryonic coronary developmental program and epicardial progenitor cell activation in adult mice in vivo.. J Mol Cell Cardiol. 46(5):728-38.
Cordes KR, Srivastava D.  2009.  MicroRNA regulation of cardiovascular development.. Circ Res. 104(6):724-32.
Ellis J, Bruneau BG, Keller G, Lemischka IR, Nagy A, Rossant J, Srivastava D, Zandstra PW, Stanford WL.  2009.  Alternative induced pluripotent stem cell characterization criteria for in vitro applications.. Cell Stem Cell. 4(3):198-9;authorreply202.
Shieh JTC, Srivastava D.  2009.  Heart malformation: what are the chances it could happen again? Circulation. 120(4):269-71.
Fish JE, Srivastava D.  2009.  MicroRNAs: opening a new vein in angiogenesis research.. Sci Signal. 2(52):pe1.
Maitra M, Schluterman MK, Nichols HA, Richardson JA, Lo CW, Srivastava D, Garg V.  2009.  Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development.. Dev Biol. 326(2):368-77.
Ieda M, Tsuchihashi T, Ivey KN, Ross RS, Hong T-T, Shaw RM, Srivastava D.  2009.  Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling.. Dev Cell. 16(2):233-44.
Nigam V, Srivastava D.  2009.  Notch1 represses osteogenic pathways in aortic valve cells.. J Mol Cell Cardiol. 47(6):828-34.
Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee T-H, Miano JM, Ivey KN, Srivastava D.  2009.  miR-145 and miR-143 regulate smooth muscle cell fate and plasticity.. Nature. 460(7256):705-10.
Kwon C, Qian L, Cheng P, Nigam V, Arnold J, Srivastava D.  2009.  A regulatory pathway involving Notch1/beta-catenin/Isl1 determines cardiac progenitor cell fate.. Nat Cell Biol. 11(8):951-7.
Niu Z, Iyer D, Conway SJ, Martin JF, Ivey K, Srivastava D, Nordheim A, Schwartz RJ.  2008.  Serum response factor orchestrates nascent sarcomerogenesis and silences the biomineralization gene program in the heart.. Proc Natl Acad Sci U S A. 105(46):17824-9.
Morton SU, Scherz PJ, Cordes KR, Ivey KN, Stainier DYR, Srivastava D.  2008.  microRNA-138 modulates cardiac patterning during embryonic development.. Proc Natl Acad Sci U S A. 105(46):17830-5.
Ivey KN, Muth A, Arnold J, King FW, Yeh R-F, Fish JE, Hsiao EC, Schwartz RJ, Conklin BR, Bernstein HS et al..  2008.  MicroRNA regulation of cell lineages in mouse and human embryonic stem cells.. Cell Stem Cell. 2(3):219-29.
Gong B, Sun J, Vargas G, Chang Q, Xu Y, Srivastava D, Boor PJ.  2008.  Nonlinear imaging study of extracellular matrix in chemical-induced, developmental dissecting aortic aneurysm: evidence for defective collagen type III.. Birth Defects Res A Clin Mol Teratol. 82(1):16-24.
Ransom JF, King IN, Garg V, Srivastava D.  2008.  A rare human sequence variant reveals myocardin autoinhibition.. J Biol Chem. 283(51):35845-52.
Kwon C, Cordes KR, Srivastava D.  2008.  Wnt/beta-catenin signaling acts at multiple developmental stages to promote mammalian cardiogenesis.. Cell Cycle. 7(24):3815-8.
Ivey KN, Sutcliffe D, Richardson J, Clyman RI, Garcia JA, Srivastava D.  2008.  Transcriptional regulation during development of the ductus arteriosus.. Circ Res. 103(4):388-95.
Fish JE, Santoro MM, Morton SU, Yu S, Yeh R-F, Wythe JD, Ivey KN, Bruneau BG, Stainier DYR, Srivastava D.  2008.  miR-126 regulates angiogenic signaling and vascular integrity.. Dev Cell. 15(2):272-84.
Saxena A, Fish JE, White MD, Yu S, Smyth JWP, Shaw RM, J DiMaio M, Srivastava D.  2008.  Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction.. Circulation. 117(17):2224-31.
Srivastava D, Saxena A, J Dimaio M, Bock-Marquette I.  2007.  Thymosin beta4 is cardioprotective after myocardial infarction.. Ann N Y Acad Sci. 1112:161-70.
Xin M, Small EM, van Rooij E, Qi X, Richardson JA, Srivastava D, Nakagawa O, Olson EN.  2007.  Essential roles of the bHLH transcription factor Hrt2 in repression of atrial gene expression and maintenance of postnatal cardiac function.. Proc Natl Acad Sci U S A. 104(19):7975-80.
Kwon C, Arnold J, Hsiao EC, Taketo MM, Conklin BR, Srivastava D.  2007.  Canonical Wnt signaling is a positive regulator of mammalian cardiac progenitors.. Proc Natl Acad Sci U S A. 104(26):10894-9.
Ransom J, Srivastava D.  2007.  The genetics of cardiac birth defects.. Semin Cell Dev Biol. 18(1):132-9.
Rajagopal SK, Ma Q, Obler D, Shen J, Manichaikul A, Tomita-Mitchell A, Boardman K, Briggs C, Garg V, Srivastava D et al..  2007.  Spectrum of heart disease associated with murine and human GATA4 mutation.. J Mol Cell Cardiol. 43(6):677-85.
Jia H, King IN, Chopra SS, Wan H, Ni TT, Jiang C, Guan X, Wells S, Srivastava D, Zhong TP.  2007.  Vertebrate heart growth is regulated by functional antagonism between Gridlock and Gata5.. Proc Natl Acad Sci U S A. 104(35):14008-13.
Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN, Tsuchihashi T, McManus MT, Schwartz RJ, Srivastava D.  2007.  Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2.. Cell. 129(2):303-17.
Schluterman MK, Krysiak AE, Kathiriya IS, Abate N, Chandalia M, Srivastava D, Garg V.  2007.  Screening and biochemical analysis of GATA4 sequence variations identified in patients with congenital heart disease.. Am J Med Genet A. 143A(8):817-23.
Zhao Y, Srivastava D.  2007.  A developmental view of microRNA function.. Trends Biochem Sci. 32(4):189-97.
Srivastava D.  2006.  Making or breaking the heart: from lineage determination to morphogenesis.. Cell. 126(6):1037-48.
Srivastava D, Yu S.  2006.  Stretching to meet needs: integrin-linked kinase and the cardiac pump.. Genes Dev. 20(17):2327-31.
Ivey KN, Srivastava D.  2006.  The paradoxical patent ductus arteriosus.. J Clin Invest. 116(11):2863-5.
Srivastava D, Ivey KN.  2006.  Potential of stem-cell-based therapies for heart disease.. Nature. 441(7097):1097-9.
King IN, Kathiriya IS, Murakami M, Nakagawa M, Gardner KA, Srivastava D, Nakagawa O.  2006.  Hrt and Hes negatively regulate Notch signaling through interactions with RBP-Jkappa.. Biochem Biophys Res Commun. 345(1):446-52.
Capellini TD, Di Giacomo G, Salsi V, Brendolan A, Ferretti E, Srivastava D, Zappavigna V, Selleri L.  2006.  Pbx1/Pbx2 requirement for distal limb patterning is mediated by the hierarchical control of Hox gene spatial distribution and Shh expression.. Development. 133(11):2263-73.
Gong B, Trent MB, Srivastava D, Boor PJ.  2006.  Chemical-induced, nonlethal, developmental model of dissecting aortic aneurysm.. Birth Defects Res A Clin Mol Teratol. 76(1):29-38.
Koshiba-Takeuchi K, Takeuchi JK, Arruda EP, Kathiriya IS, Mo R, Hui C-C, Srivastava D, Bruneau BG.  2006.  Cooperative and antagonistic interactions between Sall4 and Tbx5 pattern the mouse limb and heart.. Nat Genet. 38(2):175-83.
Srivastava D.  2006.  Genetic regulation of cardiogenesis and congenital heart disease.. Annu Rev Pathol. 1:199-213.
Aiyer AR, Honarpour N, Herz J, Srivastava D.  2005.  Loss of Apaf-1 leads to partial rescue of the HAND2-null phenotype.. Dev Biol. 278(1):155-62.
Kwon C, Han Z, Olson EN, Srivastava D.  2005.  MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling.. Proc Natl Acad Sci U S A. 102(52):18986-91.
Srivastava D.  2004.  Heart disease: an ongoing genetic battle? Nature. 429(6994):819-22.
Cowan CA, Yokoyama N, Saxena A, Chumley MJ, Silvany RE, Baker LA, Srivastava D, Henkemeyer M.  2004.  Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development.. Dev Biol. 271(2):263-71.
Yamagishi H, Srivastava D.  2003.  Unraveling the genetic and developmental mysteries of 22q11 deletion syndrome.. Trends Mol Med. 9(9):383-9.
Ivey K, Tyson B, Ukidwe P, McFadden DG, Levi G, Olson EN, Srivastava D, Wilkie TM.  2003.  Galphaq and Galpha11 proteins mediate endothelin-1 signaling in neural crest-derived pharyngeal arch mesenchyme.. Dev Biol. 255(2):230-7.
Garg V, Kathiriya IS, Barnes R, Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS, Hirayama-Yamada K, Joo K et al..  2003.  GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5.. Nature. 424(6947):443-7.
Srivastava D.  2003.  Building a heart: implications for congenital heart disease.. J Nucl Cardiol. 10(1):63-70.
Yamagishi H, Maeda J, Hu T, McAnally J, Conway SJ, Kume T, Meyers EN, Yamagishi C, Srivastava D.  2003.  Tbx1 is regulated by tissue-specific forkhead proteins through a common Sonic hedgehog-responsive enhancer.. Genes Dev. 17(2):269-81.
Yamagishi C, Hierck BP, De Groot ACGittenbe, Yamagishi H, Srivastava D.  2003.  Functional attenuation of UFD1l, a 22q11.2 deletion syndrome candidate gene, leads to cardiac outflow septation defects in chicken embryos.. Pediatr Res. 53(4):546-53.
Abe M, Tamamura Y, Yamagishi H, Maeda T, Kato J, Tabata MJ, Srivastava D, Wakisaka S, Kurisu K.  2002.  Tooth-type specific expression of dHAND/Hand2: possible involvement in murine lower incisor morphogenesis.. Cell Tissue Res. 310(2):201-12.
Gottlieb PD, Pierce SA, Sims RJ, Yamagishi H, Weihe EK, Harriss JV, Maika SD, Kuziel WA, King HL, Olson EN et al..  2002.  Bop encodes a muscle-restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesis.. Nat Genet. 31(1):25-32.
Villanueva MP, Aiyer AR, Muller S, Pletcher MT, Liu X, Emanuel B, Srivastava D, Reeves RH.  2002.  Genetic and comparative mapping of genes dysregulated in mouse hearts lacking the Hand2 transcription factor gene.. Genomics. 80(6):593-600.
Srivastava D, Gottlieb PD, Olson EN.  2002.  Molecular mechanisms of ventricular hypoplasia.. Cold Spring Harb Symp Quant Biol. 67:121-5.
Natarajan A, Yamagishi H, Ahmad F, Li D, Roberts R, Matsuoka R, Hill S, Srivastava D.  2001.  Human eHAND, but not dHAND, is down-regulated in cardiomyopathies.. J Mol Cell Cardiol. 33(9):1607-14.
Kunte A, Ivey K, Yamagishi C, Garg V, Yamagishi H, Srivastava D.  2001.  A common cis-acting sequence in the DiGeorge critical region regulates bi-directional transcription of UFD1L and CDC45L.. Mech Dev. 108(1-2):81-92.
Yamagishi H, Yamagishi C, Nakagawa O, Harvey RP, Olson EN, Srivastava D.  2001.  The combinatorial activities of Nkx2.5 and dHAND are essential for cardiac ventricle formation.. Dev Biol. 239(2):190-203.
Liu ZP, Nakagawa O, Nakagawa M, Yanagisawa H, Passier R, Richardson JA, Srivastava D, Olson EN.  2001.  CHAMP, a novel cardiac-specific helicase regulated by MEF2C.. Dev Biol. 234(2):497-509.
Garg V, Yamagishi C, Hu T, Kathiriya IS, Yamagishi H, Srivastava D.  2001.  Tbx1, a DiGeorge syndrome candidate gene, is regulated by sonic hedgehog during pharyngeal arch development.. Dev Biol. 235(1):62-73.
Srivastava D.  2001.  Genetic assembly of the heart: implications for congenital heart disease.. Annu Rev Physiol. 63:451-69.
Srivastava D, Olson EN.  2000.  A genetic blueprint for cardiac development.. Nature. 407(6801):221-6.
Fisher SA, Langille BL, Srivastava D.  2000.  Apoptosis during cardiovascular development.. Circ Res. 87(10):856-64.
Srivastava D.  2000.  Congenital heart defects: trapping the genetic culprits.. Circ Res. 86(9):917-8.
Fernandez-Teran M, Piedra ME, Kathiriya IS, Srivastava D, Rodriguez-Rey JC, Ros MA.  2000.  Role of dHAND in the anterior-posterior polarization of the limb bud: implications for the Sonic hedgehog pathway.. Development. 127(10):2133-42.
Angelo S, Lohr J, Lee KH, Ticho BS, Breitbart RE, Hill S, Yost HJ, Srivastava D.  2000.  Conservation of sequence and expression of Xenopus and zebrafish dHAND during cardiac, branchial arch and lateral mesoderm development.. Mech Dev. 95(1-2):231-7.
Srivastava D.  2000.  DiGeorge syndrome: an enigma in mice and men.. Mol Med Today. 6(1):13-4.
Yamagishi H, Olson EN, Srivastava D.  2000.  The basic helix-loop-helix transcription factor, dHAND, is required for vascular development.. J Clin Invest. 105(3):261-70.
Nakagawa O, McFadden DG, Nakagawa M, Yanagisawa H, Hu T, Srivastava D, Olson EN.  2000.  Members of the HRT family of basic helix-loop-helix proteins act as transcriptional repressors downstream of Notch signaling.. Proc Natl Acad Sci U S A. 97(25):13655-60.
McFadden DG, Charité J, Richardson JA, Srivastava D, Firulli AB, Olson EN.  2000.  A GATA-dependent right ventricular enhancer controls dHAND transcription in the developing heart.. Development. 127(24):5331-41.
Srivastava D.  1999.  Developmental and genetic aspects of congenital heart disease.. Curr Opin Cardiol. 14(3):263-8.
Srivastava D.  1999.  HAND proteins: molecular mediators of cardiac development and congenital heart disease.. Trends Cardiovasc Med. 9(1-2):11-8.
Yamagishi H, Garg V, Matsuoka R, Thomas T, Srivastava D.  1999.  A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects.. Science. 283(5405):1158-61.
Nakagawa O, Nakagawa M, Richardson JA, Olson EN, Srivastava D.  1999.  HRT1, HRT2, and HRT3: a new subclass of bHLH transcription factors marking specific cardiac, somitic, and pharyngeal arch segments.. Dev Biol. 216(1):72-84.
Firulli AB, McFadden DG, Lin Q, Srivastava D, Olson EN.  1998.  Heart and extra-embryonic mesodermal defects in mouse embryos lacking the bHLH transcription factor Hand1.. Nat Genet. 18(3):266-70.
Thomas T, Kurihara H, Yamagishi H, Kurihara Y, Yazaki Y, Olson EN, Srivastava D.  1998.  A signaling cascade involving endothelin-1, dHAND and msx1 regulates development of neural-crest-derived branchial arch mesenchyme.. Development. 125(16):3005-14.
Thomas T, Yamagishi H, Overbeek PA, Olson EN, Srivastava D.  1998.  The bHLH factors, dHAND and eHAND, specify pulmonary and systemic cardiac ventricles independent of left-right sidedness.. Dev Biol. 196(2):228-36.
Srivastava D.  1997.  Left, right ... which way to turn? Nat Genet. 17(3):252-4.
Srivastava D, Olson EN.  1997.  Knowing in your heart what's right.. Trends Cell Biol. 7(11):447-53.
Srivastava D, Thomas T, Lin Q, Kirby ML, Brown D, Olson EN.  1997.  Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND.. Nat Genet. 16(2):154-60.
Lin Q, Srivastava D, Olson EN.  1997.  A transcriptional pathway for cardiac development.. Cold Spring Harb Symp Quant Biol. 62:405-11.
Srivastava D, Olson EN.  1996.  Neurotrophin-3 knocks heart off Trk.. Nat Med. 2(10):1069-71.
Olson EN, Srivastava D.  1996.  Molecular pathways controlling heart development.. Science. 272(5262):671-6.
Srivastava D, Preminger T, Lock JE, Mandell V, Keane JF, Mayer JE, Kozakewich H, Spevak PJ.  1995.  Hepatic venous blood and the development of pulmonary arteriovenous malformations in congenital heart disease.. Circulation. 92(5):1217-22.
Srivastava D, Cserjesi P, Olson EN.  1995.  A subclass of bHLH proteins required for cardiac morphogenesis.. Science. 270(5244):1995-9.
Srivastava D, Thompson EB.  1990.  Two glucocorticoid binding sites on the human glucocorticoid receptor.. Endocrinology. 127(4):1770-8.

Ivey KN Srivastava D. Tam PPL, Nelson WJ, Rossant J, Eds. Mammalian Development: Networks, Switches, and Morphogenetic Processes. MicroRNAs as developmental regulators. 2013; 33–42.

Baldwin HS Srivastava D. Allen HD, Driscoll DJ, Shaddy RE, Feltes TF, Eds. Moss and Adams' Heart Disease in Infants, Children and Adolescents. Molecular determinants of cardiac development and disease. 2012.

Srivastava D. Rudplph's Pediatrics (Rudolph C, Rudolph A, Lister G, First L, Gershon A, Eds). Control of embryologic cardiac development. 2011.

Cordes KR, Srivastava D. Heart Development and Regeneration (Rosenthal N, Harvey R, Eds). MicroRNA regulation of cardiac development and disease. 2010; 2:729–740.

Bruneau BG, Burn J, Srivastava D. Paediatric Cardiology (Anderson RH, Baker EJ, Penny D, Redington AN, Rigby ML, Wernovsky G, Eds). The Aetiology of Congenital Cardiac Disease. 2010; 161–171.

Srivastava D, Kwon C. Handbook of Cell Signaling (Bradshaw RA, Dennis EA, Eds). Signaling pathways involved in cardiogenesis. 2009; 3:2601–2609.

Nigam V, Srivastava D. Inborn Errors of Development (Epstein CJ, Ed). Molecular regulation of cardiogenesis. 2008; 124–129.

Samal E, Srivastava D. Advances in Developmental Biology (Bodmer R, Ed). Role of microRNAs in Cardiovascular Biology. 2007; 18:167–178.

Garg V, Srivastava D. Principles of Molecular Cardiology (Runge MS, Patterson C, Eds). Genetic underpinnings of cardiogenesis and congenital heart disease. 2005.

Srivastava D, Olson EN. Molecular Basis of Cardiovascular Disease: A Companion to Braunwald's Heart Disease (Chien KR, Ed). Cardiac Development and Congenital Heart Disease. 2004.

Srivastava D. Handbook of Cell Signaling (Bradshaw RA, Dennis EA, Eds). Signaling Pathways Involved in Cardiogenesis. 2003; 3:463–470.

Srivastava D. Neonatal Cardiology (Artman M, Mahony L, Teitel DF, Eds). Molecular and morphogenetic cardiac embryology: Implications for congenital heart disease. 2002; 1–15.

Olson EN, Srivastava D. Encyclopedia of Molecular Medicine (Creighton TE and Kazazian HH, Eds). HAND transcription factors. 2001.

Srivastava D, Baldwin HS. Moss and Adams' Heart Disease in Infants, Children, and Adolescents (Allen HD, Gutsgell HP, Clark EB, Driscoll DJ, Eds). Molecular determinants of cardiac development. 2001.

Yamagishi H, Srivastava D. Etiology and Morphogenesis of Congenital Heart Disease (Clark EB, Nakazawa M, Takao A, Eds). Role of the bHLH transcription factor, dHAND, in cranial/cardiac neural crest development. 2000; 325–328.

Srivastava D. Etiology and Morphogenesis of Congenital Heart Disease (Takao A, Nakazawa M, Clark EB, Eds). Understanding CHD through dissection of segmental cardiac molecular pathways. 2000; 205–210.

Srivastava D. Heart Development (Rosenthal N and Harvey R, Eds). Segmental regulation of cardiac development by the basic helix-loop-helix transcription factors dHAND and eHAND. 1999; 143–155.

Srivastava D. Genetic Control of Heart Development (Harvey RP, Olson EN, Schulz RA, Altman JS, Eds). The bHLH proteins, dHAND and eHAND in cardiac development. 1997.